ICD 10 CM M11.15 | Description & Clinical Information

ICD 10 M11.15 describes a genetic condition known as familial chondrocalcinosis, which is characterized by the accumulation of calcium pyrophosphate dihydrate (CPPD) crystals in the cartilage of the hip joint, leading to calcification and progressive damage to the joint, and is inherited due to a defective gene.

Official Description Of M11.15

The ICD 10 CM book defines ICD 10 code M11.15 as:

When To Use M11.15

The diagnosis describes a condition referred to as familial chondrocalcinosis of the hip. The disease is characterized by pain, swelling, stiffness, tenderness, and restricted movement of the joint. Medical providers rely on a combination of methods to diagnose this condition, including a review of the patient’s family history, physical examination by a professional, imaging techniques such as Xrays, and laboratory examination of synovial fluid samples to look for crystals. If the diagnosis code ICD 10 CM M11.15 is recorded in the patient’s medical records, it implies that the patient has been diagnosed with familial chondrocalcinosis of the hip.

One tool used to diagnose this rare condition is a family history that reveals the presence of the disease in at least two members of the same family. A positive history may also reveal that the signs and symptoms experienced by the patient are consistent with familial chondrocalcinosis of the hip. Alternatively, a medical provider may rely on a physical examination, which involves assessing the affected joint for tenderness, swelling, and reduced mobility. Blood tests may be ordered to help rule out other diseases with similar symptoms, but the primary diagnostic tool remains examination of joint fluid obtained via aspiration. Crystal analysis of the synovial fluid can help confirm the presence of calcium pyrophosphate dihydrate crystals that point to the genetic origin of this condition.

In terms of treatment options, the choice depends on the severity of the disease and the patient’s preferred route. The illness usually requires a combination of treatments aimed at reducing the risk of further attacks, minimizing the adverse effects of joint inflammation, and managing pain. Such therapies may include rest, physical therapy, splints, and other supportive devices. Aspiration of joint fluid and the administration of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine may be prescribed to relieve pain and inflammation. In advanced cases, surgery may be necessary to repair the affected joint.

Familial chondrocalcinosis of the hip is not a life-threatening condition, but it can significantly impact one’s quality of life. If left untreated, it can lead to joint damage, disability, and chronic pain. Therefore, seeking medical attention is crucial for anyone displaying symptoms of this disease. While there is no known cure for familial chondrocalcinosis of the hip condition, timely diagnosis and management can significantly improve the patient’s symptoms and maximize the patient’s ability to live a healthy and active life. In conclusion, proper and accurate diagnosis helps patients receive appropriate treatment that would improve their quality of life.